Clinical Trials Logo
  1. Home
  2. Uterine Cervical Neoplasm
  3. NCT05880485

Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer

Uterine Cervical Neoplasm Clinical Trial

Official title:
A Prospective Study to Evaluate Online Adaptive Radiotherapy in Cervical Cancer With Reduced Margin

Clinical Trial Summary

Online adaptive radiotherapy (oART) has demonstrated to be feasible to reduce planning target volume (PTV) margins for cervical cancer. To explore the value of reduced margins in oART for cervical cancer, we conducted a prospective clinical trial to determine the clinical efficacy and toxicity of reduced margins.

Clinical Trial Description

This is an investigator-initiated efficacious, single-center, open-label clinical trial study. This study hypothesizes that the use of reduced PTV margins in oART for cervical cancer could decrease toxicity and achieve more accurate dosimetric coverage. A dose of 50.4 Gy is delivered to clinical target volume (CTV) with reduced margin oART. Patients receive cisplatin based concurrent chemotherapy. The primary endpoint is acute toxicity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05880485
Study type Interventional
Source Peking Union Medical College Hospital
Contact
Status Active, not recruiting
Phase Phase 1/Phase 2
Start date February 2, 2023
Completion date November 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04114968 - Offering Cervical Cancer Screening to Older Women
Active, not recruiting NCT05682950 - Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer Phase 2
Completed NCT05022511 - Three Birds With One Stone N/A
Recruiting NCT06439706 - HPV Self-sampling for Underscreened Latinas N/A
Active, not recruiting NCT05869123 - Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer Phase 1/Phase 2
Recruiting NCT03739944 - Different Surgical Approaches in Patients of Early-stage Cervical Cancer Phase 3
Terminated NCT03020121 - Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples N/A
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Active, not recruiting NCT03994055 - Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer N/A
Recruiting NCT03955185 - Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer N/A
Recruiting NCT04974424 - Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
Recruiting NCT03308591 - Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients Phase 3
Terminated NCT03100409 - Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients N/A
Not yet recruiting NCT03971032 - An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure N/A
Recruiting NCT04516616 - Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Phase 2
Recruiting NCT04061967 - SMS-based Summons in Cervical Screening N/A
Completed NCT03122275 - Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer N/A